BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10752638)

  • 1. Regioselective hydroxylation of debrisoquine by cytochrome P4502D6: implications for active site modelling.
    Lightfoot T; Ellis SW; Mahling J; Ackland MJ; Blaney FE; Bijloo GJ; De Groot MJ; Vermeulen NP; Blackburn GM; Lennard MS; Tucker GT
    Xenobiotica; 2000 Mar; 30(3):219-33. PubMed ID: 10752638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship.
    Dorado P; Berecz R; Cáceres MC; González I; Cobaleda J; Llerena A
    Clin Chem Lab Med; 2005; 43(3):275-9. PubMed ID: 15843230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio.
    Zhen Y; Slanar O; Krausz KW; Chen C; Slavík J; McPhail KL; Zabriskie TM; Perlík F; Gonzalez FJ; Idle JR
    Drug Metab Dispos; 2006 Sep; 34(9):1563-74. PubMed ID: 16782768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Hydroxylation of debrisoquine by human CYP1A1 and its inhibition by quinidine and quinine.
    Granvil CP; Krausz KW; Gelboin HV; Idle JR; Gonzalez FJ
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1025-32. PubMed ID: 12023534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6.
    Ellis SW; Hayhurst GP; Lightfoot T; Smith G; Harlow J; Rowland-Yeo K; Larsson C; Mahling J; Lim CK; Wolf CR; Blackburn MG; Lennard MS; Tucker GT
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):565-71. PubMed ID: 10642515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Debrisoquine metabolism and CYP2D expression in marmoset liver microsomes.
    Cooke BR; Bligh SW; Cybulski ZR; Ioannides C; Hall M
    Drug Metab Dispos; 2012 Jan; 40(1):70-5. PubMed ID: 21976620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1- and 3-hydroxylations, in addition to 4-hydroxylation, of debrisoquine are catalyzed by cytochrome P450 2D6 in humans.
    Eiermann B; Edlund PO; Tjernberg A; Dalén P; Dahl ML; Bertilsson L
    Drug Metab Dispos; 1998 Nov; 26(11):1096-101. PubMed ID: 9806952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity.
    Llerena A; Dorado P; Peñas-Lledó EM
    Pharmacogenomics; 2009 Jan; 10(1):17-28. PubMed ID: 19102711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes.
    McManus ME; Boobis AR; Minchin RF; Schwartz DM; Murray S; Davies DS; Thorgeirsson SS
    Cancer Res; 1984 Dec; 44(12 Pt 1):5692-7. PubMed ID: 6498831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling.
    Wolff T; Distlerath LM; Worthington MT; Groopman JD; Hammons GJ; Kadlubar FF; Prough RA; Martin MV; Guengerich FP
    Cancer Res; 1985 May; 45(5):2116-22. PubMed ID: 3921236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic consistency in hydroxylation of desmethylimipramine and debrisoquine in healthy subjects and in human liver microsomes.
    Spina E; Birgersson C; von Bahr C; Ericsson O; Mellström B; Steiner E; Sjöqvist F
    Clin Pharmacol Ther; 1984 Nov; 36(5):677-82. PubMed ID: 6488689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thioridazine dosage on the debrisoquine hydroxylation phenotype in psychiatric patients with different CYP2D6 genotypes.
    LLerena A; Berecz R; de la Rubia A; Fernández-Salguero P; Dorado P
    Ther Drug Monit; 2001 Dec; 23(6):616-20. PubMed ID: 11802093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of CYP2D6 activity by treatment with propranolol and the role of 4-hydroxy propranolol.
    Rowland K; Yeo WW; Ellis SW; Chadwick IG; Haq I; Lennard MS; Jackson PR; Ramsay LE; Tucker GT
    Br J Clin Pharmacol; 1994 Jul; 38(1):9-14. PubMed ID: 7946944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of tricyclic antidepressant drugs, debrisoquine and 7-ethoxyresorufin, by human liver preparations.
    von Bahr C; Birgersson C; Morgan ET; Eriksson O; Göransson M; Spina E; Woodhouse K
    Xenobiotica; 1986 May; 16(5):391-400. PubMed ID: 3739365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolism of aprindine in relation to the sparteine/debrisoquine polymorphism.
    Ebner T; Eichelbaum M
    Br J Clin Pharmacol; 1993 Apr; 35(4):426-30. PubMed ID: 8485023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A three-dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation.
    Islam SA; Wolf CR; Lennard MS; Sternberg MJ
    Carcinogenesis; 1991 Dec; 12(12):2211-9. PubMed ID: 1747920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of debrisoquine hydroxylation with quinidine in subjects with three or more functional CYP2D6 genes.
    Dalén P; Dahl M; Andersson K; Bertilsson L
    Br J Clin Pharmacol; 2000 Feb; 49(2):180-4. PubMed ID: 10671914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6.
    Llerena A; Edman G; Cobaleda J; Benítez J; Schalling D; Bertilsson L
    Acta Psychiatr Scand; 1993 Jan; 87(1):23-8. PubMed ID: 8424321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of plasma proteins with cytochromes P450 mediated metabolic reactions: inhibition by human serum albumin and alpha-globulins of the debrisoquine 4-hydroxylation (CYP2D) in liver microsomes of human, hamster and rat.
    Ishii M; Xu BQ; Ding LR; Fischer NE; Inaba T
    Toxicol Lett; 2001 Mar; 119(3):219-25. PubMed ID: 11246175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinated intrahepatic and extrahepatic regulation of cytochrome p4502D6 in healthy subjects and in patients after liver transplantation.
    Carcillo JA; Adedoyin A; Burckart GJ; Frye RF; Venkataramanan R; Knoll C; Thummel K; Roskos L; Wilson JW; Sereika S; Romkes M; Bebia Z; Branch RA
    Clin Pharmacol Ther; 2003 May; 73(5):456-67. PubMed ID: 12732845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.